No Data
No Data
InfuSystem to Participate in Lytham Partners Fall 2024 Investor Conference on October 1, 2024
InfuSystem a New Buy at B Riley on Infusion Pump Business
InfuSystems Holdings Analyst Ratings
B.Riley Financial Initiates InfuSystems(INFU.US) With Buy Rating, Announces Target Price $13
Craig-Hallum Maintains InfuSystems(INFU.US) With Buy Rating
Craig-Hallum analyst Matt Hewitt maintains $InfuSystems(INFU.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 42.1% and a total average return of -4.2% over the
Craig-Hallum Maintains InfuSystems(INFU.US) With Buy Rating, Cuts Target Price to $8
Craig-Hallum analyst Matt Hewitt maintains $InfuSystems(INFU.US)$ with a buy rating, and adjusts the target price from $15 to $8.According to TipRanks data, the analyst has a success rate of 42.2%